Of adults receiving tirzepatide who had no or minimal depression symptoms at baseline, 79.4% remained in that category through the end of safety follow-up, 17% reported mild depression symptoms, 2.9% had moderate symptoms, 0.7% reported moderately severe symptoms and 0.1% had severe symptoms
There are 3 specific mechanisms: 1
If a result seems absent, the problem is often the product, not your biology
This matters even more when youre on GLP-1 medications
Well monitor your health closely to minimize any risks
However, if redness persists for more than one week or is accompanied by increasing warmth, spreading inflammation, pus, or fever, contact your GP as these may indicate infection requiring medical assessment